Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K/AKT/FoxO1 pathway

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is a worldwide health problem with high prevalence and morbidity associated with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and dyslipidemia. Nano-formulation of luteolin with Zn oxide in the form of Lut/ZnO NPs may improve the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Esraa SA, Mohamed, Hebatallah E, Farrag, Mostafa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630902/
https://www.ncbi.nlm.nih.gov/pubmed/36319192
http://dx.doi.org/10.1177/03946320221137435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630902/
https://www.ncbi.nlm.nih.gov/pubmed/36319192
http://dx.doi.org/10.1177/03946320221137435

Ejemplares similares